Examining the patient and caregiver experience with diazepam nasal spray for seizure clusters: Results from an exit survey of a phase 3, open-label, repeat-dose safety study

Authors

Patricia Penovich, Minnesota Epilepsy Group
James W Wheless, University of Tennessee Health Science Center
R Edward Hogan, Washington University School of Medicine in St. Louis
Cynthia Guerra, Neurelis, Inc.
David F Cook, Neurelis, Inc.
Enrique Carrazana, Neurelis, Inc.
Adrian L Rabinowicz, Neurelis, Inc.

Journal

Epilepsy & Behavior

Publication Date

8-1-2021

Volume

121

Issue

Part A

First Page

108013

Document Type

Open Access Publication

DOI

10.1016/j.yebeh.2021.108013

Rights and Permissions

Penovich P, Wheless JW, Hogan RE, Guerra C, Cook DF, Carrazana E, Rabinowicz AL. Examining the patient and caregiver experience with diazepam nasal spray for seizure clusters: Results from an exit survey of a phase 3, open-label, repeat-dose safety study. Epilepsy Behav. 2021 Aug;121(Pt A):108013. doi: 10.1016/j.yebeh.2021.108013 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Penovich, Patricia; Wheless, James W; Hogan, R Edward; Guerra, Cynthia; Cook, David F; Carrazana, Enrique; and Rabinowicz, Adrian L, "Examining the patient and caregiver experience with diazepam nasal spray for seizure clusters: Results from an exit survey of a phase 3, open-label, repeat-dose safety study." Epilepsy & Behavior. 121, Part A. 108013 (2021).
https://digitalcommons.wustl.edu/oa_4/402